Back

Type I interferon and MAVS signaling restricts chikungunya virus heart infection and cardiac tissue damage

Noval, M. G.; Bartnicki, E.; Spector, S. N.; Izzo, F.; Damani-Yokota, P.; Narula, N.; Yeung, S. T.; Rodriguez-Rodriguez, B. A.; Dewan, M. Z.; Mezzano, V.; Loomis, C.; Khanna, K. M.; Stapleford, K. A.

2022-05-27 microbiology
10.1101/2022.05.27.493768 bioRxiv
Show abstract

Chikungunya virus (CHIKV) infection has been associated with severe cardiac manifestations, yet, how CHIKV infection leads to heart disease remains unknown. Here, we leveraged both mouse models and human primary cells to define the mechanisms of CHIKV heart infection. We found that CHIKV actively replicates in cardiac fibroblasts and is cleared without significant tissue damage through the induction of a local type-I interferon response from both infected and non-infected cardiac cells. Importantly, signaling through the mitochondrial antiviral-signaling protein (MAVS) is required for viral clearance from the heart. In the absence of MAVS, persistent infection leads to focal myocarditis and major vessel vasculitis persisting for up to 60 days post-infection, suggesting CHIKV can lead to vascular inflammation and potential long-lasting cardiovascular complications. This study provides a model of CHIKV cardiac infection and mechanistic insight into CHIKV-induced heart disease, underscoring the importance of monitoring cardiac function in patients with CHIKV infections.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.